ESC 365 - Drug treatment of hypertension to prevent atrial fibrillation and in patients with atrial fibrillation

Open Access

Drug treatment of hypertension to prevent atrial fibrillation and in patients with atrial fibrillation

Session: Atrial fibrillation and hypertension: implications for clinical practice

Topic: Hypertension, other

Speaker: Doctor T. Aksnes (Oslo, NO)

Event: ESC CONGRESS 2016

Congress Session

About the speaker

Doctor Tonje Aksnes

Oslo University Hospital Rikshospitalet, Oslo (Norway)

1 presentation

0 follower

3 more presentations in this session

Hypertensive phenotype and risk of atrial fibrillation

Speaker: Associate Professor M. Losi (Naples, IT)

ECG and circulating biomarkers to stratify atrial fibrillation risk

Speaker: Associate Professor G. Schillaci

Stroke prevention and anticoagulation in non valvular atrial fibrillation in hypertension

Speaker: Professor J. Camm (London, GB)

Access the full session

Atrial fibrillation and hypertension: implications for clinical practice

Speakers: Doctor T. Aksnes, Associate Professor M. Losi, Associate Professor G. Schillaci, Professor J. Camm

About the event

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

Congress

This platform is supported by